NRBO Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Neurobo Pharmaceuticals Inc - Alpha Spread

Neurobo Pharmaceuticals Inc
NASDAQ:NRBO

Watchlist Manager
Neurobo Pharmaceuticals Inc Logo
Neurobo Pharmaceuticals Inc
NASDAQ:NRBO
Watchlist
Price: 3.61 USD -1.1% Market Closed
Market Cap: 29.7m USD
Have any thoughts about
Neurobo Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

NRBO Price Targets Summary
Neurobo Pharmaceuticals Inc

There are no price targets for NRBO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Neurobo Pharmaceuticals Inc Competitors:
Price Targets
ALEC
Alector Inc
133% Upside
6160
Beigene Ltd
25% Upside
VTGN
VistaGen Therapeutics Inc
303% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
73% Upside
MREO
Mereo Biopharma Group PLC
72% Upside
VYGR
Voyager Therapeutics Inc
188% Upside
VTVT
vTv Therapeutics Inc
86% Downside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
2% Downside

Revenue
Forecast

Revenue Estimate
Neurobo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Neurobo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Neurobo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NRBO's stock price target?
Not Available

NRBO doesn't have any price targets made by Wall Street professionals.

Back to Top